DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Current Program Funding Opportunities

Funding Opportunities

Synopsis of Current Program Funding Opportunities

FY19 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Therapeutic Development Award Program Announcement
Application Instructions
November 20, 2019
  • Maximum funding of $1.0 million for direct costs (plus indirect costs); $1.25 million for direct costs (plus indirect costs) for applications including the Therapeutically Relevant Marker Option.
  • Maximum period of performance is 2 years.
 Pre-Application: March 22, 2019

Pre-Application is required; Full application submission is by invitation only.

Application: July 25, 2019
Therapeutic Idea Award Program Announcement
Application Instructions
November 20, 2019
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application: March 22, 2019

Pre-Application is required; Full application submission is by invitation only.

Application: July 25, 2019


FY19 Autism Research Program (ARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		March 18, 2019
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs).

Early-Career Investigator Partnering PI Option:

  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $1,155,000 for direct costs (plus indirect costs).
 Pre-Application:
May 1, 2019

Invitation to Submit an Application:
June 10, 2019

Application:
August 8, 2019
Idea Development Award Program Announcement
Application Instructions 		March 18, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs).
  • For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $500,000 in direct costs (plus indirect costs).
 Pre-Application:
May 1, 2019

Invitation to Submit an Application:
June 10, 2019

Application:
August 8, 2019
Clinical Translational Research Award Program Announcement
Application Instructions 		March 18, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs).
 Pre-Application:
May 1, 2019

Invitation to Submit an Application:
June 10, 2019

Application:
August 8, 2019



FY19 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 Program Announcement
Application Instructions
 January 22, 2019 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 1 with Partnering PI Option:
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2:
  • Maximum funding of $1M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2 with Partnering PI Option:
  • Maximum funding of $ 1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2 – Population Science and Prevention Studies:
  • Maximum funding of $ 1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:
  • Maximum funding of $ 2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019
Breakthrough Award Level 3 Program Announcement
Application Instructions
 January 22, 2019 Funding Level 3:
  • Maximum funding of $3M in direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Funding Level 3 with Partnering PI Option:
  • Maximum funding of $4M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal): March 12, 2019

Invited Application:
June 13, 2019
Breakthrough Award Level 4 Program Announcement
Application Instructions
 January 22, 2019 Funding Level 4 and Funding Level 4 with Partnering PI Option:
  • Maximum funding of $10M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal): March 12, 2019

Invited Application:
June 13, 2019
Era of Hope Scholar Award Program Announcement
Application Instructions
 January 22, 2019
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019

Confidential Letters of Recommendation Submission Deadline: April 2, 2019
Innovator Award Program Announcement
Application Instructions
 January 22, 2019
  • Maximum funding of $5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal): March 12, 2019

Invited Application: June 13, 2019

Confidential Letters of Recommendation Submission Deadline: June 18, 2019
Distinguished Investigator Award Program Announcement
Application Instructions
 January 22, 2019
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal): March 12, 2019

Invited Application: June 13, 2019

Confidential Letters of Recommendation Submission Deadline: June 18, 2019
Breakthrough Fellowship Award Program Announcement
Application Instructions
 January 22, 2019
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019

Confidential Letters of Recommendation Submission Deadline: April 2, 2019


FY19 Defense Medical Research and Development Program (DMRDP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
FY19 Investigator Initiated Research Award (IIRA) Program Announcement

Intramural investigators and organizations must apply through CDMRP eBRAP 		March 6, 2019
  • Anticipated that budgets will not exceed $750K in total costs.
  • Period of performance not to exceed 3 years.
 Pre-Application (Preproposal):
April 22, 2019

Preproposal is required; application submission is by invitation only.

Application:
August 7, 2019

FY19 Defense Medical Research and Development Program (DMRDP) Combat Casualty Care Research Program (JPC-6)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
FY19 Multi-Domain Lifesaving Trauma Innovations (MuLTI) Award Program Announcement
Application Instructions 		January 18, 2019 For studies involving prospective accrual of human subjects and clinical trials::
  • Maximum funding of $2.5 million (M) for total costs.
  • The maximum period of performance is 3 years.
For all other research:
  • Maximum funding of $1.0M for total costs.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
March 5, 2019

Inivted Application:
May 29, 2019


FY19 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Concept Award
  • Maximum funding of $100,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 1 year
 PENDING RELEASE

DEADLINE TO BE DETERMINED
Career Development Award Program Announcement
Application Instructions
 March 22, 2019
  • Maximum funding of $250,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years
 Pre-Application (Letter of Intent):
August 01, 2019

Letter of Intent is required.

Application: August 21, 2019
Idea Development Award Program Announcement
Application Instructions
 March 22, 2019
  • Maximum funding of $350,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years
 Pre-Application (Preproposal): May 15, 2019

Preproposal is required; application submission is by invitation only.

Application: August 21, 2019
Investigator Initiated Translational Research Award Program Announcement
Application Instructions
 March 22, 2019
  • Maximum funding of $400,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years
 Pre-Application (Preproposal): May 15, 2019

Preproposal is required; application submission is by invitation only.

Application: August 21, 2019
Translational Research Partnership Award Program Announcement
Application Instructions
 March 22, 2019
  • Maximum funding of $900,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 3 years
 Pre-Application (Preproposal): May 15, 2019

Preproposal is required; application submission is by invitation only.

Application: August 21, 2019


FY19 Military Burn Research Program (MBRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
 March 1, 2019
  • Maximum funding of $500,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
April 17, 2019

Invitation to Submit an Application:
May 17, 2019

Application:
July 10, 2019
Clinical Translational Research Award Program Announcement
Application Instructions
 March 1, 2019
  • Maximum funding of $1.55 million for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal):
April 17, 2019

Invitation to Submit an Application:
May 17, 2019

Application:
July 10, 2019

FY19 Neurofibromatosis Research Program (NFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		March 11, 2019
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $800,000 in direct costs ($1,000,000 in direct costs if requesting the Qualified Collaborator Option).
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
May 23, 2019

Application:
June 6, 2019
Exploration - Hypothesis Development Award Program Announcement
Application Instructions 		March 11, 2019
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
May 23, 2019

Application:
June 6, 2019
Investigator-Initiated Research Award Program Announcement
Application Instructions 		March 21, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $525,000 in direct costs.
  • The maximum allowable funding for applications including either the Optional Qualified Collaborator or the NF-OSI Option is $575,000 in direct costs.
  • The maximum allowable funding for applications including both the Optional Qualified Collaborator Option and the NF-OSI Option is $625,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
May 23, 2019

Application:
June 6, 2019
New Investigator Award Program Announcement
Application Instructions 		March 11, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
May 23, 2019

Application:
June 6, 2019
Early Investigator Research Award Program Announcement
Application Instructions 		March 11, 2019
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $200,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
May 23, 2019

Confidential Letters of Recommendation:
June 11, 2019

Application:
June 6, 2019

FY19 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Development Award Program Announcement
Clinical Development Award – Early-Career Investigator Option Eligibility Statement
Application Instructions 		March 1, 2019
  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum funding of $800,000 for direct costs with a qualified nested Early Career Investigator (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application:
April 30, 2019

Application:
July 31, 2019
Investigator-Initiated Research Award Program Announcement
Application Instructions 		February 22, 2019
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application:
April 23, 2019

Application:
July 24, 2019
Ovarian Cancer Academy Award - Early-Career Investigator Program Announcement
Application Instructions 		February 22, 2019
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application:
April 30, 2019

Application:
July 31, 2019
Ovarian Cancer Academy Dean and Assistant Dean (Leadership) Award Program Announcement
Application Instructions 		February 22, 2019
  • Maximum funding of $1,750,000 for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
 Pre-Application:
April 30, 2019

Application:
July 31, 2019
Pilot Award Program Announcement
Application Instructions 		February 22, 2019
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application:
April 23, 2019

Application:
July 24, 2019


FY19 Parkinson's Research Program (PRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions 		March 22, 2019
  • Maximum funding of $360,000 for total costs (includes direct and indirect costs)
  • Maximum period of performance is 2 years
 Pre-Application (Letter of Intent):
July 9, 2019

Application:
July 24, 2019
Investigator-Initiated Research Award Program Announcement
Application Instructions 		March 22, 2019 Individual PIs:
  • Maximum funding of $1.5 million (M) for total costs (includes direct and indirect costs)
  • Maximum Period of performance is 3 years
Partnering PI Option:
  • Maximum funding of $2.4 million (M) for total costs (includes direct and indirect costs)
  • Maximum period of performance is 3 years
 Pre-Application (Letter of Intent):
July 9, 2019

Application:
July 24, 2019


FY19 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions 		March 21, 2019
  • Maximum funding for the entire period of performance is $360,000 in direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
August 21, 2019

Application: September 11, 2019
Horizon Award Program Announcement
Application Instructions 		March 21, 2019
  • Maximum funding for the entire period of performance is $150,000 in direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent):
August 21, 2019

Application: September 11, 2019
Idea Award with Special Focus Program Announcement
Application Instructions 		March 21, 2019
  • Maximum funding for the entire period of performance is $400,000 in direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Preproposal):
May 22, 2019

Preproposal is required; Application submission is by invitation only.

Application:
September 11, 2019
Impact Award Program Announcement
Application Instructions 		March 21, 2019
  • Maximum funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
May 22, 2019

Preproposal is required; Application submission is by invitation only.

Application: September 11, 2019
Translational Team Science Award Program Announcement
Application Instructions 		March 21, 2019
  • Maximum funding for the entire period of performance is $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal):
May 22, 2019

Preproposal is required; Application submission is by invitation only.

Application:
September 11, 2019

FY19 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Discovery Award Program Announcement
Application Instructions 		January 15, 2019
  • Maximum funding of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years
 Pre-Application (Letter of Intent): March 28, 2019

Application: April 11, 2019
Clinical Trial Award Program Announcement
Application Instructions 		January 15, 2019
  • No maximum funding limit; requested funding must be justifiable and appropriate for the scope of work proposed; budget will be considered during pre-application screening and will be a scored full application criterion
  • Maximum period of performance is 4 years
 Pre-Application (Preproposal): March 14, 2019

Application: July 2, 2019
Focused Program Award Program Announcement
Application Instructions 		January 15, 2019
  • Maximum funding of $7.2 million for direct costs (plus indirect costs)
  • Maximum period of performance is 4 years
 Pre-Application (Preproposal): March 14, 2019

Application: July 2, 2019
Investigator-Initiated Research Award Program Announcement
Application Instructions 		January 15, 2019
  • Maximum funding of $1.2 million for direct costs (plus indirect costs); $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option
  • Maximum period of performance is 3 years
 Pre-Application (Preproposal): March 14, 2019

Application: July 11, 2019
Technology/Therapeutic Development Award Program Announcement
Application Instructions 		January 15, 2019
  • Maximum funding of $3 million for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years
 Pre-Application (Preproposal): March 14, 2019

Application: July 11, 2019






FY19 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions 		February 19, 2019
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019
Idea Development Award Program Announcement
Application Instructions 		February 19, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019
Clinical Translational Research Award Program Announcement
Application Instructions 		February 19, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019

Last updated Friday, March 22, 2019